Zoetis Inc Class A
ZTS: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|#% | LOCK|?%B | LOCK|%>K!fhR |
Zoetis Earnings: Mixed Quarterly Results Keep Zoetis on Track for 2025
Zoetis reported second-quarter results that included reported revenue and earnings growth of 4% and 15%, respectively. Adjusted for the sale of the medicated feed additives and foreign currency, quarterly sales grew 8% year over year.
